INDICATIONS AND USAGE
Tofaxha is a Janus Kinase (JAK) inhibitor used for:
Rheumatoid Arthritis: Adult patients with moderately to severely active rheumatoid arthritis an monotherapy or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).
Psoriatic Arthritics: Adult patients with active psoriatic arthritis.
Ulcerative Colitis: Adult patients with moderately to severely active Ulcerative Colitis (UC).
DOSAGE AND ADMINISTRATION
Rheumatoid Arthritis: 5 mg twice daily.
Psoriatic Arthritics: 5 mg twice daily.
Ulcerative Colitis: 10 mg twice daily for at least 8 weeks; then 5 or 10 mg with or without food.
DOSAGE FORMS AND STRENGTHS
Film-coated tablets: 5 mg and 10 mg.
STORAGE OF TOFAXHA
Store TOFAXHA at room temperature (up to 30°C).